期刊文献+

外周T细胞淋巴瘤的药物治疗进展

下载PDF
导出
摘要 外周T细胞淋巴瘤(FFCL)为异质性血液学肿瘤组,起源于成熟T细胞,预后较差。目前该病的治疗尚处于探索阶段,很多新药的研究正在进行,新的药物组合方案的尝试也已展开,从很大程度上提高了该类患者的临床疗效与预后。本文着重于探索目前PTCL的药物治疗进展。
出处 《徐州医学院学报》 CAS 2012年第4期277-280,共4页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献22

  • 1Savage K J, FelTeri A J, Zinzani PL, et al. Peripheral T - cell lym- phoma - - not otherwise specified [ J ]. Crit Rev Oncol Hemat, 2011,79 ( 3 ) :321 - 329.
  • 2Piekarz RL, Frye R, Prince HM, et al. Phase 2 trial of romidep- sin in patients with peripheral T - cell lymphoma [ J ]. Blood, 2011,117(22) :5827 -5834.
  • 3Armitage J, Vose J, Weisenburger D. International peripheral T - cell and natural killer/T - cell lymphoma study : pathology findings and clinical outcomes [ J ]. J Clin Oncol, :2008, 26 (25) :4124 - 4130.
  • 4Sehmitz N, T~imper L, Ziepert M, et al. Treatment and prognosis of mature T - cell and NK - cell lymphoma: analysis of patients with T - cell lymphoma treated in studies of the German High - Grade Non- Hodgkin Lymphoma Study Group [J]. Blood, 2010, 116(18) : 3418 -3425.
  • 5Zelenetz AD, Abramson JS, Advani RH, et al. NCCN Clinical Practice Guidelines in Oncology: non - Hodgkin' s lymphomas [J]. J Natl Compr Canc Netw, 2010, 8(3) :288 -334.
  • 6Zinzani PL, Venturini F, Stefoni V, et al. Gemcitabine as single agent in pretreated T - cell lymphoma patients : evaluation of the long - term outcome [ J]. Ann Oncol, 2010,21 (4) :860 - 863.
  • 7王学文,李锋.外周T细胞淋巴瘤的研究进展[J].现代肿瘤医学,2009,17(6):1173-1178. 被引量:10
  • 8O'Connor OA, Pro B, Pinter - Brown L, et al. Pralatrexate in pa- tients with relapsed or refractory peripheral T - cell lymphoma : re- suits from the pivotal PROPEL study [ J]. J Clin Oncol,2011,29 (9) :1182 - 1189.
  • 9Mould DR, Sweeney K, Duffull SB, et al. A population pharma- cokinetic and phammcodynamic evaluation of pralatrexate in pa- tients with relapsed or refractory non - Hodgkin' s or Hodgkin' s lymphoma [ J ]. Clin Pharmacol Ther, 2009,86 ( 2 ) : 190 - 196.
  • 10Dang NH, Pro B, Hagemeister FB, et al. Phase II trial of de- nileukin diftitox for relapsed/refractory T - cell non - Hodgkin lymphoma [Jl. Br J Haematol, 2007,136(3):439-447.

二级参考文献35

  • 1The Non-Hodgkin's Lymphoma Classification Project.A clinical evaluation of the International Lymphoma Study Group classication of non-Hodgkin's lymphoma[J].Blood,1997,89(11):3909-3918.
  • 2Vose JM.International Peripheral T-cell Lymphoma(PTCL)Clinical and Pathologic Review Project:poor outcome by prognostic indices and lack of efficacy with anthracyclines[J].Blood,2005,1006(11):239.
  • 3Rudiger T,Geissinger E,Muller-Hermelink HK.Normal counterparts' of nodal peripheral T-cell lymphoma[J].Hematol Oncol,2006,24(4):175-180.
  • 4Delves PJ,Roitt IM.The immune system.Second of two parts[J].N Engl J Med,2000,343(2):108-117.
  • 5Delves PJ,Roitt IM.The immune system.First of two parts[J].N Engl J Med,2000,343(1):37-49.
  • 6Stein H,Foss HD,Durkop H,et al.CD30(+)anaplastic large cell lymphoma:a review of its histopathologic,genetic,and clinical features[J].Blood,2000,97(12):3681-3695.
  • 7Chen CY,Yao M,Tang JL,et al.Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan:with special reference to T-cell lymphoma[J].Ann Oncol,2004,15(7):1091-1096.
  • 8Martinez-Delgado B,Cuadros M,Honrado E,et al.Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas[J].Leukemia,2005,19(12):2254-2263.
  • 9Ralfkiaer E,Muller-Hermelink HK,Jaffe ES.Peripheral T-cell lymphoma,unspecified[A].Jaffe ES,Harris NL,Stein H,et al.World Health Organization classification of tumours.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001:227-229.
  • 10Armitage JO,Cavalli F,Zucca E,eds.Text atlas of lymphomas(revised edition)[M].London:Martin Dunitz,2002:30-43.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部